478 related articles for article (PubMed ID: 17062703)
21. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.
Kozlow W; Guise TA
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):169-80. PubMed ID: 16025223
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin in prostate cancer bone metastasis.
Corey E; Brown LG; Kiefer JA; Quinn JE; Pitts TE; Blair JM; Vessella RL
Cancer Res; 2005 Mar; 65(5):1710-8. PubMed ID: 15753366
[TBL] [Abstract][Full Text] [Related]
23. Biology of bone metastases: causes and consequences.
Harvey HA; Cream Lv
Clin Breast Cancer; 2007 Jul; 7 Suppl 1():S7-S13. PubMed ID: 17683652
[TBL] [Abstract][Full Text] [Related]
24. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
[TBL] [Abstract][Full Text] [Related]
25. Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition.
McCabe NP; Madajka M; Vasanji A; Byzova TV
Clin Exp Metastasis; 2008; 25(5):581-90. PubMed ID: 18506587
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.
Nakajima K; Kho DH; Yanagawa T; Harazono Y; Hogan V; Chen W; Ali-Fehmi R; Mehra R; Raz A
Cancer Res; 2016 Mar; 76(6):1391-402. PubMed ID: 26837763
[TBL] [Abstract][Full Text] [Related]
27. Myeloma and bone disease: "the dangerous tango".
Epstein J; Walker R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):300-6. PubMed ID: 16728940
[TBL] [Abstract][Full Text] [Related]
28. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.
Das S; Samant RS; Shevde LA
J Biol Chem; 2011 Mar; 286(11):9612-22. PubMed ID: 21169638
[TBL] [Abstract][Full Text] [Related]
29. Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro.
Krawetz R; Wu YE; Rancourt DE; Matyas J
Exp Cell Res; 2009 Aug; 315(14):2333-42. PubMed ID: 19433087
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondins in bone remodeling and metastatic bone disease.
Carminati L; Taraboletti G
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
[TBL] [Abstract][Full Text] [Related]
31. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR
J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.
Giuliani N; Rizzoli V; Roodman GD
Blood; 2006 Dec; 108(13):3992-6. PubMed ID: 16917004
[TBL] [Abstract][Full Text] [Related]
33. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
[TBL] [Abstract][Full Text] [Related]
34. Review of cellular mechanisms of tumor osteolysis.
Clohisy DR; Perkins SL; Ramnaraine ML
Clin Orthop Relat Res; 2000 Apr; (373):104-14. PubMed ID: 10810467
[TBL] [Abstract][Full Text] [Related]
35. Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
Schwaninger R; Rentsch CA; Wetterwald A; van der Horst G; van Bezooijen RL; van der Pluijm G; Löwik CW; Ackermann K; Pyerin W; Hamdy FC; Thalmann GN; Cecchini MG
Am J Pathol; 2007 Jan; 170(1):160-75. PubMed ID: 17200191
[TBL] [Abstract][Full Text] [Related]
36. Osteolytic and osteoblastic metastases due to carcinoid tumors.
Manoli RS; Barthelemy CR
Clin Nucl Med; 1980 Mar; 5(3):102-5. PubMed ID: 7357764
[TBL] [Abstract][Full Text] [Related]
37. [Pathophysiology of bone metastases in urologic carcinomas].
Sauer G; Barth TF; Möller P
Urologe A; 2007 Aug; 46(8):888-90. PubMed ID: 17632696
[TBL] [Abstract][Full Text] [Related]
38. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
[TBL] [Abstract][Full Text] [Related]
39. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
Reddi AH; Roodman D; Freeman C; Mohla S
J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]